Apria Inc Revenue Growth Rates (APR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Apria inc   (NASDAQ: APR)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

APR's Revenue Growth by Quarter and Year

Apria Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APR Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December 296.53
3rd Quarter September 287.20
2nd Quarter June 286.28
1st Quarter March 275.27
FY 1,145.27





APR Revenue fourth quarter 2021 Y/Y Growth Comment
Apria inc reported Revenue growth of 0.93% year on year in the fourth quarter 2021, to $ 296.53 millions, this is lower than Apria Inc 's recent average Revenue growth of 2.52%.

Looking into fourth quarter 2021 results within Healthcare Facilities industry 22 other companies have achieved higher Revenue growth. While Apria Inc ' s Revenue increase of 0.93% ranks overall at the positon no. 2051 in the fourth quarter 2021.


APR Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December 0.93 % - - -
3rd Quarter September 3.77 % - - -
2nd Quarter June 6.45 % - - -
1st Quarter March 2.24 % - - -
FY   3.3 % - - -

Financial Statements
Apria Inc 's fourth quarter 2021 Revenue $ 296.53 millions APR's Income Statement
Apria Inc 's fourth quarter 2020 Revenue $ 293.79 millions Quarterly APR's Income Statement


APR Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December 3.25 % 6.15 % - -
3rd Quarter September 0.32 % 2.91 % - -
2nd Quarter June 4 % -0.11 % - -
1st Quarter March -6.3 % - - -
FY (Year on Year)   3.3 % - - -


Back to APR Growth rate Comparisons >> Back to APR Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #368
Overall #2051

Revenue Y/Y Growth Statistics
High Average Low
4 % 2.52 % 0.32 %
(Jun 30 2021)   (Sep 30 2021)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #368
Overall #2051
Revenue Y/Y Growth Statistics
High Average Low
4 % 2.52 % 0.32 %
(Jun 30 2021)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Apria Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4 % 2.52 % 0.32 %
(Jun 30 2021)  


APR's IV. Quarter Q/Q Revenue Comment
Apria inc achieved in the IV. Quarter 2021 above company average sequential Revenue growth of 3.25%, to $ 296.53 millions, from $287.20 millions in the third quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Apria Inc 's Revenue growth quarter on quarter, overall rank is 2054.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #367
Overall #2054
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #23
Healthcare Sector #367
Overall #2054
Revenue Q/Q Growth Statistics
High Average Low
4 % 2.52 % 0.32 %
(Jun 30 2021)  


APR's IV. Quarter Q/Q Revenue Comment
Apria inc achieved in the IV. Quarter 2021 above company average sequential Revenue growth of 3.25%, to $ 296.53 millions, from $287.20 millions in the third quarter.

Within Healthcare Facilities industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Apria Inc 's Revenue growth quarter on quarter, overall rank is 2054.


Apria Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 1,145.28 $ 0.00 $ 0.00 $ 275.27 $ 0.00
Y / Y Revenue Growth (TTM) 3.3 % - - - -
Year on Year Revenue Growth Overall Ranking # 3670 # 3670 # 3670 # 3670 # 3670
Seqeuential Revenue Change (TTM) 0.24 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3670 # # # #


Cumulative Revenue growth Comment
With 3.3% annual Revenue growth, Apria Inc would report a record annual Revenue improvement if the fiscal year would end on Dec 31 2021.

In the Healthcare sector 503 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 3670.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 37
Healthcare Sector # 504
Overall # 3601

Revenue TTM Y/Y Growth Statistics
High Average Low
3.3 %
 3.3 %
3.3 %
(Dec 31 2021)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 517
S&P 500 # 3779
Cumulative Revenue growth Comment
With 3.3% annual Revenue growth, Apria Inc would report a record annual Revenue improvement if the fiscal year would end on Dec 31 2021.

In the Healthcare sector 503 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 3670.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 37
Healthcare Sector # 504
Overall # 3601

Revenue TTM Y/Y Growth Statistics
High Average Low
3.3 %
3.3 %
3.3 %
(Dec 31 2021)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 517
S&P 500 # 3779




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
APR's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Fresenius Medical Care Ag1.62%$ 1.616 millions
Exact Sciences Corporation1.60%$ 1.602 millions
Bionik Laboratories Corp 1.60%$ 1.602 millions
Bellicum Pharmaceuticals Inc 1.60%$ 1.600 millions
Amedisys Inc1.56%$ 1.564 millions
Galapagos Nv1.42%$ 1.421 millions
Embecta Corp 1.40%$ 1.402 millions
Alimera Sciences Inc1.34%$ 1.343 millions
Davita Inc 1.33%$ 1.330 millions
Cormedix Inc 1.22%$ 1.224 millions
Orasure Technologies Inc1.13%$ 1.134 millions
Dentsply Sirona Inc 1.12%$ 1.115 millions
Vycor Medical Inc 1.08%$ 1.079 millions
Invacare Holdings Corporation0.96%$ 0.959 millions
Amneal Pharmaceuticals Inc 0.95%$ 0.952 millions
Apria inc 0.93%$ 0.931 millions
Royalty Pharma Plc0.62%$ 0.622 millions
Neurometrix Inc 0.58%$ 0.576 millions
Vanda Pharmaceuticals Inc 0.54%$ 0.541 millions


About Apria Inc Revenue Growth Rates (APR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Apria Inc (CIK 1735803).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-22-004507
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Apria Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.